Enlaza Therapeutics Announces Strategic Collaboration With Vertex Pharmaceuticals

San Diego – September 2, 2025 – Cooley advised Enlaza Therapeutics, the first covalent biologics platform company, on its multi-target drug discovery collaboration with Vertex Pharmaceuticals, to utilize Enlaza’s proprietary War-Lock technology platform to develop small format drug conjugates and T-cell engagers for certain autoimmune diseases and improved conditioning in sickle cell disease and beta thalassemia.    Under the terms of the collaboration, Enlaza will receive $45 million inclusive of…

  • Post category:Cooley Law Firm
  • Reading time:3 mins read
Continue ReadingEnlaza Therapeutics Announces Strategic Collaboration With Vertex Pharmaceuticals

Thirty Madison to Be Acquired by Remedy Meds

New York – September 3, 2025 – Cooley advised Thirty Madison, a specialty healthcare company offering high-quality virtual specialized care for patients experiencing a range of conditions, on its definitive agreement to be acquired by Remedy Meds in an all-stock transaction valued in excess of $500 million. Lawyers Izzy Lubarsky, Adam Dinow, Bill Roegge, Jenny Ge, Teddy Nimetz and Scott Rudin led the Cooley team advising Thirty Madison. Cooley previously…

  • Post category:Cooley Law Firm
  • Reading time:2 mins read
Continue ReadingThirty Madison to Be Acquired by Remedy Meds

TBO to Acquire Classic Vacations From the Najafi Companies

Palo Alto – September 3, 2025 – Cooley advised TBO, a leading global travel distribution platform, on its agreement to acquire Classic Vacations from Arizona-based investment firm, the Najafi Companies. India-based TBO (NSE India: TBOTEK) aims to simplify the buying and selling travel needs of travel partners across the world, and this acquisition brings together the power of TBO’s first-class technology platform and worldwide inventory with Classic Vacation’s vast network…

  • Post category:Cooley Law Firm
  • Reading time:2 mins read
Continue ReadingTBO to Acquire Classic Vacations From the Najafi Companies

Hong Kong Exchange’s Confidential Filing Option Lures Tech Listing Hopefuls, Law Firm Says

Michael Yu, partner in charge of Cooley’s Hong Kong office, was quoted in a South China Morning Post article about the increase in biotech and tech initial public offering (IPO) applications in Hong Kong. Cooley also was mentioned for advising Innogen Pharmaceutical on its IPO, the eighth completed Hong Kong IPO for the firm in 2025. Read the article This content is provided for general informational purposes only, and your…

  • Post category:Cooley Law Firm
  • Reading time:2 mins read
Continue ReadingHong Kong Exchange’s Confidential Filing Option Lures Tech Listing Hopefuls, Law Firm Says

1WorldSync Acquired by Syndigo

Boston – September 3, 2025 – Cooley advised 1WorldSync, a portfolio company of Battery Ventures and a leader in product content orchestration, on its acquisition by Syndigo, creating a $3.5 billion+ enterprise backed by Summit Partners, TJC LP and Battery Ventures. Together, the company powers 90% of the top 20 retailers in the US as the leading artificial intelligence-first software provider behind ecommerce product pages. Lawyers Alfred Browne, Izzy Lubarsky,…

  • Post category:Cooley Law Firm
  • Reading time:2 mins read
Continue Reading1WorldSync Acquired by Syndigo

New Executive Order Increases Oversight of Award and Performance of Federal Grants

An executive order (EO) issued August 7, 2025, Improving Oversight of Federal Grantmaking, announced significant changes in the way federal grants are awarded and administered. The Trump administration’s bases for the proposed overhaul, as described in the EO, include concern over whether certain federal grants are truly advancing the public interest, whether oversight in grants administration is sufficient to ensure their efficacy and perceived shortcomings in the grant review process.…

  • Post category:Cooley Law Firm
  • Reading time:5 mins read
Continue ReadingNew Executive Order Increases Oversight of Award and Performance of Federal Grants

AI in the Workplace: US Legal Developments

Recent federal, state and litigation developments in artificial intelligence (AI) use in the workplace highlight the growing tension between fostering innovation and safeguarding against discrimination and other harms arising from using AI tools at work. This alert outlines key developments from this year and offers compliance tips for employers. Federal developments Guidance withdrawn, moratorium falters In a February 2025 Cooley alert, we reported that many federal agencies, including the Equal…

  • Post category:Cooley Law Firm
  • Reading time:14 mins read
Continue ReadingAI in the Workplace: US Legal Developments

Cooley Adds Emerging Companies and Venture Capital Partner in Singapore

Singapore – September 4, 2025 – David He has joined Cooley as an emerging companies and venture capital partner in the firm’s Singapore office. He brings more than a decade of experience advising venture capital and private equity funds, as well as startups and technology companies across the world. During this time, he was based in New York, Silicon Valley and Asia. He’s practice covers the life cycle of high-growth…

  • Post category:Cooley Law Firm
  • Reading time:4 mins read
Continue ReadingCooley Adds Emerging Companies and Venture Capital Partner in Singapore

CFPB Narrows Its Supervision of Nonbanks

On Tuesday, August 26, the Consumer Financial Protection Bureau (CFPB) announced a proposed rule that would likely decrease the number of nonbanks it supervises under Section 1024(a)(1)(C) of the Consumer Financial Protection Act (CFPA). Under this provision, the CFPB may supervise a nonbank company engaged in conduct that it has reasonable cause to determine poses “risks to consumers” with respect to the nonbank’s offering or provision of financial products or…

  • Post category:Cooley Law Firm
  • Reading time:5 mins read
Continue ReadingCFPB Narrows Its Supervision of Nonbanks

Hengrui Pharma and Braveheart Bio Enter Into Exclusive License Agreement

New York – September 5, 2025 – Cooley advised Hengrui Pharma, a global pharmaceutical company, on its exclusive license agreement with Braveheart Bio for HRS-1893, a small-molecule inhibitor of cardiac myosin independently developed by Hengrui Pharma with best-in-class potential. Hengrui Pharma is eligible to receive potential development and commercial milestone payments of up to $1.013 billion, in addition to related royalties based on net sales. Under the terms of the…

  • Post category:Cooley Law Firm
  • Reading time:3 mins read
Continue ReadingHengrui Pharma and Braveheart Bio Enter Into Exclusive License Agreement

Wugen Secures $115 Million Series C Financing

San Diego – September 5, 2025 – Cooley advised Wugen, a clinical-stage biotechnology company, on its $115 million Series C financing. The company is a pioneer in the next generation of allogeneic, off-the-shelf chimeric antigen receptor T-cell (CAR-T) therapies. Fidelity Management & Research Company led the financing, with participation from RiverVest Venture Partners, Lightchain Capital, Abingworth, ICG, LYZZ Capital, Tybourne Capital Management, Aisling Capital Management and other leading life sciences…

  • Post category:Cooley Law Firm
  • Reading time:2 mins read
Continue ReadingWugen Secures $115 Million Series C Financing

Cooley Again Named a California Legal Powerhouse

For the third consecutive year, Cooley was named a California Powerhouse by Law360 on the publication’s annual list of regional powerhouses, a compendium reflecting not only the work of exemplary firms but also emerging legal trends in each state. Cooley was recognized on the prestigious list with other California firms that “epitomized the industries and recurring legal issues within the Golden State, handling intellectual property litigation, privacy and securities class…

  • Post category:Cooley Law Firm
  • Reading time:2 mins read
Continue ReadingCooley Again Named a California Legal Powerhouse

Litigator of the Week: Shoutout

Cooley partner Reuben Chen led a team of litigators that earned a shoutout on The American Lawyer’s Litigation Daily Litigator of the Week Runners-Up and Shout-Outs list for its successful representation of client RSB Spine. After first winning a patent infringement jury trial against Johnson & Johnson’s DePuy unit, the team turned back an attempt to undo Cooley’s $12 million trial verdict. In recent weeks, the firm successfully represented RSB…

  • Post category:Cooley Law Firm
  • Reading time:2 mins read
Continue ReadingLitigator of the Week: Shoutout

Baseten Secures $150 Million Series D

Palo Alto – September 5, 2025 – Cooley advised Baseten, a company powering inference for the world’s fastest-growing artificial intelligence products, on its $150 million Series D financing, valuing the company at $2.15 billion. The round was led by BOND, with participation from new investors CapitalG, Premji, and Kevin and Elizabeth Weil of Scribble, as well as existing investors Conviction, 01a, IVP, Spark and Greylock. This new round of funding…

  • Post category:Cooley Law Firm
  • Reading time:2 mins read
Continue ReadingBaseten Secures $150 Million Series D

To Carry Out EO, SBA Orders Its Lenders to Review and End Debanking Practices

On August 26, the US Small Business Administration (SBA) instructed its network of more than 5,000 lenders to “cease any politicized or unlawful debanking actions,” in direct response to President Donald Trump’s recent Executive Order (EO) 14331, “Guaranteeing Fair Banking Access for All Americans.” The EO, issued on August 7, directs “Federal banking regulators,” including the SBA, to remediate past instances and prevent against future acts of politicized or unlawful…

  • Post category:Cooley Law Firm
  • Reading time:4 mins read
Continue ReadingTo Carry Out EO, SBA Orders Its Lenders to Review and End Debanking Practices

Cooley Receives Multiple Life Sciences Awards

New York – September 5, 2025 – Two Cooley life sciences attorneys received awards from LMG Life Sciences in its 13th annual Americas Awards program. The firm’s Washington, DC-based Eric Greig was named Regulatory Attorney of the Year for Pricing and Reimbursement. Greig recently joined the firm as a partner advising clients on healthcare regulatory, market access and reimbursement strategies across the pharmaceutical, medical device, digital health, biotechnology and healthcare services…

  • Post category:Cooley Law Firm
  • Reading time:3 mins read
Continue ReadingCooley Receives Multiple Life Sciences Awards

PaaS, IaaS or SaaS – Be Aware: New Switching Rules Will Become Applicable in EU

Key takeaways for cloud, SaaS, edge and other digital service providers Introduction On September 12, 2025, sweeping new rules under the EU Data Act (Regulation (EU) 2023/2854) will become applicable, introducing significant new obligations for cloud service providers in the European Union (EU), particularly around interoperability, termination rights and switching between providers. These rules are designed to make it significantly easier for customers of data processing services to switch between…

  • Post category:Cooley Law Firm
  • Reading time:8 mins read
Continue ReadingPaaS, IaaS or SaaS – Be Aware: New Switching Rules Will Become Applicable in EU

Cooley Advises Uber on $2.25 Billion Investment-Grade Bond Offering

San Francisco – September 8, 2025 – Cooley advised Uber Technologies (NYSE: UBER), a technology platform that uses a massive network, leading technology, operational excellence and product expertise to power movement from point A to point B, on its $2.25 billion investment-grade bond offering. Lawyers Mischi a Marca, Jason Savich and Matt Kong led the Cooley team advising Uber on debt matters, while Eric Blanchard, Carlos Ramirez, Siana Lowrey, David…

  • Post category:Cooley Law Firm
  • Reading time:3 mins read
Continue ReadingCooley Advises Uber on $2.25 Billion Investment-Grade Bond Offering

Infleqtion to Go Public Through Merger With Churchill Capital Corp X

Colorado – September 8, 2025 – Cooley advised Infleqtion, a global leader in neutral atom-based quantum technology, on its definitive business combination agreement with Churchill Capital Corp X, with the aim to accelerate Infleqtion’s mission to commercialize quantum products that provide orders of magnitude improvement in computing and precision sensing applications. The business combination values Infleqtion at a pre-money equity value of $1.8 billion and is expected to provide more…

  • Post category:Cooley Law Firm
  • Reading time:2 mins read
Continue ReadingInfleqtion to Go Public Through Merger With Churchill Capital Corp X

Maryland’s Unique State Privacy Law Takes Effect October 1 – What You Should Know

On October 1, Maryland’s law may be the last US state comprehensive privacy law to take effect in 2025, but it certainly is not least. While the Maryland Online Data Privacy Act of 2024 (MODPA) mirrors existing US state comprehensive privacy laws in many ways, certain key differences may pose unusual and operational challenges for businesses subject to the law, some of which we outline below. Lower thresholds and narrower…

  • Post category:Cooley Law Firm
  • Reading time:5 mins read
Continue ReadingMaryland’s Unique State Privacy Law Takes Effect October 1 – What You Should Know

Property Finder Announces $525 Million Strategic Investment Led by Permira and Blackstone

London and Singapore – September 9, 2025 – Property Finder, a top property portal in the Middle East and North Africa, announced a combined investment of $525 million, led by funds managed by Permira and Blackstone. As part of the transaction, General Atlantic, which had been a cornerstone investor of Property Finder, undertook a secondary sale of part of its stake. Cooley advised Michael Lahyani, the founder and CEO of Property…

  • Post category:Cooley Law Firm
  • Reading time:2 mins read
Continue ReadingProperty Finder Announces $525 Million Strategic Investment Led by Permira and Blackstone

China’s Biotech Industry Is on the Rise. Will It Reshape US Pharma?

Cooley partner Lila Hope was quoted extensively in a Chemical & Engineering News article about the new life sciences and biotech companies in China and her optimistic outlook on the US biopharmaceutical industry. Read the article This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP,…

  • Post category:Cooley Law Firm
  • Reading time:2 mins read
Continue ReadingChina’s Biotech Industry Is on the Rise. Will It Reshape US Pharma?

Tourmaline Bio Enters Into Agreement to be Acquired by Novartis

New York – September 9, 2025 – Cooley advised Tourmaline Bio (NASDAQ: TRML), a late-stage clinical biotechnology company developing transformative medicines that establish new standards of care for patients with life-altering inflammatory and immune diseases, on its merger agreement with Novartis. Under the terms of the agreement, Novartis will acquire Tourmaline for $48 per share in cash at closing, or a total equity value of approximately $1.4 billion. Completion of…

  • Post category:Cooley Law Firm
  • Reading time:2 mins read
Continue ReadingTourmaline Bio Enters Into Agreement to be Acquired by Novartis

MAHA Targets Social Media in Push for Tighter Controls Over Direct-to-Consumer Pharmaceutical Advertising

The Make America Healthy Again (MAHA) Commission released the Make Our Children Healthy Again Strategy (MAHA Strategy) this week. The MAHA Strategy, a cornerstone of the MAHA movement championed by Secretary of Health and Human Services Robert F. Kennedy, Jr. and embraced by President Donald Trump in Executive Order 14212, “Establishing the President’s Make America Healthy Again Commission,” outlines more than 120 initiatives, including one focused on curbing misleading direct-to-consumer…

  • Post category:Cooley Law Firm
  • Reading time:5 mins read
Continue ReadingMAHA Targets Social Media in Push for Tighter Controls Over Direct-to-Consumer Pharmaceutical Advertising

D-day for New ‘Failure to Prevent’ Offense

Tom Epps, white collar defense and investigations partner at Cooley, was quoted in The Law Society Gazette about the entry into force of the “failure to prevent fraud” offense under the UK Economic and Corporate Transparency Act 2023. In the article, Epps describes the act as a “landmark piece of legislation,” emphasizing its potential to significantly strengthen UK enforcement capabilities against fraud and other economic crimes. He also predicts a…

  • Post category:Cooley Law Firm
  • Reading time:2 mins read
Continue ReadingD-day for New ‘Failure to Prevent’ Offense

Fed Signals Fraud a Top Priority in Special Compliance Outlook Issue

The Federal Reserve (Fed) has devoted its entire Second Issue 2025 of Consumer Compliance Outlook (Outlook) to fraud – a rare, single-topic focus that underscores regulators’ and industry’s heightened concern for addressing financial fraud. The Outlook’s special fraud issue was published amid sharply rising fraud and scam losses. US consumers reported $12.5 billion lost to fraud in 2024, a 25% jump from 2023. Banks are feeling the strain too –…

  • Post category:Cooley Law Firm
  • Reading time:5 mins read
Continue ReadingFed Signals Fraud a Top Priority in Special Compliance Outlook Issue

Out-Licensing Is In

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute…

  • Post category:Cooley Law Firm
  • Reading time:2 mins read
Continue ReadingOut-Licensing Is In

MAHA Food Strategy Puts Chemicals, Dyes, GRAS and Kids’ Marketing Under the Microscope

The Make America Healthy Again (MAHA) Commission released the Make Our Children Healthy Again Strategy (MAHA Strategy) this week. Consistent with the MAHA Strategy’s overall theme of increasing transparency and trust with the American public, the Department of Health and Human Services (HHS) and the Food and Drug Administration (FDA) plan to take several key actions in the food space, including reforming the process for establishing food that is Generally…

  • Post category:Cooley Law Firm
  • Reading time:5 mins read
Continue ReadingMAHA Food Strategy Puts Chemicals, Dyes, GRAS and Kids’ Marketing Under the Microscope

CPSC Stepping up Enforcement of Recalls, AHFA Presenter Says

Cooley special counsel, Asha Allam, was mentioned in Home News Now about her presentation at the American Home Furnishings Alliance (AHFA) 2025 Regulatory Summit, where she explained that the US Consumer Product Safety Commission (CPSC) was intensifying its enforcement of product recalls. Allam said that furniture makers, retailers and distributors must proactively report potential hazards and demonstrate product safety – or risk civil penalties and even criminal investigations. Read the…

  • Post category:Cooley Law Firm
  • Reading time:2 mins read
Continue ReadingCPSC Stepping up Enforcement of Recalls, AHFA Presenter Says

Cooley Files Amicus Brief Supporting Continued Application of the Internal Affairs Doctrine in New York

New York – March 28, 2024 – Cooley has filed an amicus brief in the New York Court of Appeals on behalf of 47 corporate law professors in support of the continued application of the internal affairs doctrine. Lawyers Kathleen Hartnett, Patrick Hayden, Samantha Kirby, Alex Kasner, Amie Simmons and Madeleine McNally led the Cooley effort. The amicus brief was filed in Eccles v. Shamrock Capital Advisors, a case in…

  • Post category:Cooley Law Firm
  • Reading time:4 mins read
Continue ReadingCooley Files Amicus Brief Supporting Continued Application of the Internal Affairs Doctrine in New York

Cooley, ACLU File Amicus Brief in Idaho Emergency Abortion Care Case

San Francisco – March 29, 2024 – Cooley, alongside the American Civil Liberties Union (ACLU) and ACLU of Idaho, filed an amicus brief with the US Supreme Court on March 28 in Idaho and Moyle, et al. v. United States in support of allowing emergency abortion care to any patient who needs it. Lawyers Kathleen Hartnett and Patrick Hayden led the Cooley team. In August 2022, the Department of Justice…

  • Post category:Cooley Law Firm
  • Reading time:3 mins read
Continue ReadingCooley, ACLU File Amicus Brief in Idaho Emergency Abortion Care Case

Cooley, Cybersecurity Leaders File Brief Opposing SEC’s SolarWinds Cyberattack Case

Updated March 29, 2024 – Joined by over 50 cybersecurity leaders, including 20+ new signers, Cooley filed an updated amicus brief that supports SolarWinds’ motion to dismiss the SEC’s amended complaint, which contains more than 50 pages of additional allegations against SolarWinds and its chief information security officer. The brief’s latest signers have served in senior cybersecurity roles at major companies, such as Bank of America, Capital One, Eptura, EY, IHS…

  • Post category:Cooley Law Firm
  • Reading time:4 mins read
Continue ReadingCooley, Cybersecurity Leaders File Brief Opposing SEC’s SolarWinds Cyberattack Case

FCC Adopts New Minimum Standards for Broadband Services

The Federal Communications Commission (FCC), in a Report to Congress, has adopted new standards for determining when internet services are fast enough to qualify as broadband services. The report sets the speed threshold at 100 megabits per second (Mbps) for downstream traffic and 20 Mbps for upstream traffic for fixed services; 35 Mbps downstream and three Mbps upstream for mobile service; and one gigabit per second (Gbps) downstream per 1,000…

  • Post category:Cooley Law Firm
  • Reading time:4 mins read
Continue ReadingFCC Adopts New Minimum Standards for Broadband Services

Tri-Seal Compliance Note Highlights Broad Reach of US Trade Controls, Obligations of Non-US Persons

On 6 March 2024, the US Department of Commerce, Department of the Treasury and Department of Justice issued a Tri-Seal Compliance Note (compliance note) advising foreign-based companies and individuals to assess their obligations with respect to US export control and sanctions laws and regulations (trade controls) and implement appropriate measures designed to achieve compliance. This compliance note follows a prior publication issued by the same three agencies in July 2023…

  • Post category:Cooley Law Firm
  • Reading time:5 mins read
Continue ReadingTri-Seal Compliance Note Highlights Broad Reach of US Trade Controls, Obligations of Non-US Persons

California Releases Workplace Violence Prevention Guidance

California’s Division of Occupational Safety and Health (Cal/OSHA) recently published guidance to assist employers in complying with Senate Bill 553 ahead of the law’s employer compliance date of July 1, 2024. As we reported in November 2023, SB 553 requires virtually all employers to develop, implement, and maintain an “effective” written workplace violence prevention plan (WVPP), as well as train employees, and create and maintain extensive records regarding workplace violence.…

  • Post category:Cooley Law Firm
  • Reading time:7 mins read
Continue ReadingCalifornia Releases Workplace Violence Prevention Guidance

UK Introduces Export Controls for Emerging Technologies

On 12 March 2024, the UK Export Control Joint Unit (ECJU) announced that UK export control regulations would be amended to introduce new controls on the export of emerging technologies and provide a number of technical updates. Implemented through the Export Control (Amendment) Regulations 2024, the amendments are set to come into force on 1 April 2024. The Export Control Order 2008 The regulations introduce new export controls on military…

  • Post category:Cooley Law Firm
  • Reading time:3 mins read
Continue ReadingUK Introduces Export Controls for Emerging Technologies

Cooley Recognized for Three Deals of the Year in China

Beijing, Hong Kong and Shanghai – March 19, 2024 – Cooley was honored for its work on three Deals of the Year in 2023 by China Business Law Journal (CBLJ). The publication noted the firm for deals across three practice areas – including mergers & acquisitions, private equity financing, and life sciences partnering and licensing. Each year, CBLJ recognizes the best Chinese and international law firms in various practice area…

  • Post category:Cooley Law Firm
  • Reading time:3 mins read
Continue ReadingCooley Recognized for Three Deals of the Year in China

Playing Nice in the Sandbox: FDA (Finally) Harmonizes Medical Device Manufacturing Requirements With ISO

On February 2, 2024, the US Food and Drug Administration (FDA) published a much-awaited final rule: the Quality Management System Regulation (QMSR).1  By issuing this rule, FDA amended the medical device current good manufacturing practice (cGMP) requirements of 21 CFR Part 820 – the Quality System Regulation (QSR) – to align more closely with the quality management system (QMS) requirements used by other countries. The QMSR incorporates by reference the…

  • Post category:Cooley Law Firm
  • Reading time:12 mins read
Continue ReadingPlaying Nice in the Sandbox: FDA (Finally) Harmonizes Medical Device Manufacturing Requirements With ISO

Federal District Court Rules Corporate Transparency Act Unconstitutional, but Law Remains in Effect

Last Friday, a federal court in Alabama ruled in National Small Business United v. Yellen that the beneficial ownership information (BOI) reporting requirements established by the Corporate Transparency Act (CTA) are unconstitutional. These CTA provisions, implemented through the BOI reporting rule promulgated by the US Department of the Treasury’s Financial Crimes Enforcement Network (FinCEN) in September 2022, just started taking effect on January 1, 2024. Pursuant to the CTA and the…

  • Post category:Cooley Law Firm
  • Reading time:4 mins read
Continue ReadingFederal District Court Rules Corporate Transparency Act Unconstitutional, but Law Remains in Effect

Full attention on Critical Technology in the EU

The European Commission’s Recommendation on critical technology areas for the EU’s economic security, issued on October 3, 2023, kick-started an urgent risk assessment by policymakers and private sector stakeholders across the European Union. While this work will be completed over the next few months, policymakers have already given a strong indication that four technology areas – advanced semiconductors, artificial intelligence, quantum technologies and biotech – are critical for the EU’s…

  • Post category:Cooley Law Firm
  • Reading time:4 mins read
Continue ReadingFull attention on Critical Technology in the EU